证券记录 · 已归档季度
MBX
MBX Biosciences, Inc. Common Stock · Healthcare · Biotechnology
10被追踪持有人
-1Δ持有人
8.10M持有股份
$92.45M报告持仓市值
+1新建仓位
−2清仓
动量输入（同类管理人）：
持有人广度 -9.1% ·
股份流向 +20.3% ·
净新建仓位 -10.0%
— 公式
集中积累 — 持股数量上升但持有人减少
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 67 | +5 | 22.03M | $1.22B | +10 | −5 |
| Q1 2026 | 65 | +3 | 17.55M | $523.43M | +9 | −6 |
| Q4 2025 | 61 | +2 | 15.34M | $483.77M | +2 | — |
| Q3 2025 | 15 | +2 | 13.00M | $227.48M | +2 | — |
| Q2 2025 | 10 | -1 | 8.10M | $92.45M | +1 | −2 |
| Q1 2025 | 8 | 0 | 4.62M | $34.08M | +2 | −2 |
| Q4 2024 | 8 | -2 | 5.08M | $93.07M | — | −2 |
| Q3 2024 | 9 | +9 | 4.81M | $122.94M | +9 | — |
持有人 · Q2 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 2.27M | -14.1% | $25.86M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 2 | Wellington Management ✦ | 2.27M | -14.1% | $25.86M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 3 | Wellington Management ✦ | 2.27M | -14.1% | $25.86M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 4 | T. Rowe Price ✦ | 1.35M | +22.3% | $15.37M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | T. Rowe Price ✦ | 1.35M | +22.3% | $15.37M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 6 | The Vanguard Group ✦ (被动) | 1.04M | — | $11.91M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | The Vanguard Group ✦ (被动) | 1.04M | — | $11.91M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | The Vanguard Group ✦ (被动) | 1.04M | — | $11.91M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (被动) | 1.01M | — | $11.54M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (被动) | 1.01M | — | $11.54M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (被动) | 1.01M | — | $11.54M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (被动) | 1.01M | — | $11.54M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | BlackRock ✦ (被动) | 1.01M | — | $11.54M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | BlackRock ✦ (被动) | 1.01M | — | $11.54M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Point72 Asset Management ✦ | 973.79K | +781.4% | $11.11M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 16 | Millennium Management ✦ | 766.84K | +349.9% | $8.75M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 17 | Geode Capital Management ✦ (被动) | 348.45K | +27.0% | $3.98M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 18 | Geode Capital Management ✦ (被动) | 348.45K | +27.0% | $3.98M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 19 | State Street Global Advisors ✦ (被动) | 265.12K | +49.6% | $3.03M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 20 | Fidelity (FMR) ✦ | 61.33K | — | $699,810 | 0.0% | n/c | 1 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 18.00K | 新增 | $205,392 | 0.0% | New | 1 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 18.00K | 新增 | $205,392 | 0.0% | New | 1 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 18.00K | 新增 | $205,392 | 0.0% | New | 1 | SEC ↗ |
| 24 | AQR Capital Management ✦ | 18.00K | 新增 | $205,392 | 0.0% | New | 1 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| AQR Capital Management | $205,392 | 0.0% |
| AQR Capital Management | $205,392 | 0.0% |
| AQR Capital Management | $205,392 | 0.0% |
| AQR Capital Management | $205,392 | 0.0% |
已清仓
| Marshall Wace | $820,739 | 曾为 0.0% |
| Two Sigma Investments | $249,688 | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 156 持有人, 52.39M 股份, $1.53B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2025 ·
方法论 ·
通过API获取此数据